Drug-like molecular compounds
Molecular building blocks
Drug-like molecular compounds are biologically active, high-throughput screening drugs for compounds consisting of molecular building blocks and fragments. One screening typically uses millions of compounds.
The market capacity of library compounds used for screenign worldwide is approximately $5 billion annually.
Molecular building blocks are the main splicing module of molecules constituting drug molecules or drug-like compounds, and are the main intermediate for drug development and production.
The global molecular building block product market exceeds $50 billion.
FTE is a research and development outsourcing service business. CDMO is a customized process R&D and production outsourcing service business. The company's strong R&D strength can build a first-class outsourcing business platform.
The FTE market has exceeded $10 billion and the CDMO market has exceeded $100 billion.
From the molecular block library and the drug-like molecular compound library, we select the products with large market demand and high added value, and develop the technology to carry out large scale production or commission processing from kilogram to tonnage.
There are hundreds of billions of RMBs in the market for selected products.